Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia: a Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial

NCT07129460 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

NCT NCT07129460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07129460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia: a Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
May 1, 2027
Enrollment
204 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric intestinal metaplasia